APA (7th ed.) Citation

Carucci, M., Clamp, A., Zhou, C., Hurt, C., Glasspool, R., Monaghan, P. J., . . . Irving, A. (2024). The VALTIVE1 study protocol: A study for the validation of Tie2 as the first tumour vascular response biomarker for VEGF inhibitors. BMC Cancer, 24(1), 1. https://doi.org/10.1186/s12885-024-13073-0

Chicago Style (17th ed.) Citation

Carucci, Margherita, et al. "The VALTIVE1 Study Protocol: A Study for the Validation of Tie2 as the First Tumour Vascular Response Biomarker for VEGF Inhibitors." BMC Cancer 24, no. 1 (2024): 1. https://doi.org/10.1186/s12885-024-13073-0.

MLA (9th ed.) Citation

Carucci, Margherita, et al. "The VALTIVE1 Study Protocol: A Study for the Validation of Tie2 as the First Tumour Vascular Response Biomarker for VEGF Inhibitors." BMC Cancer, vol. 24, no. 1, 2024, p. 1, https://doi.org/10.1186/s12885-024-13073-0.